Momin Khan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Molecular Docking

Structure Activity Relationship

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Farida Begum, Muhammad Yousaf, Sajid Iqbal, Nazif Ullah, Anwar Hussain, Momin Khan, Asaad Khalid, Alanood S Algarni, Ashraf N Abdalla, Ajmal Khan, Muhammad Arif Lodhi, Ahmed Al Harrasi
Inhibition of Acetylcholinesterase with Novel 1, 3, 4, Oxadiazole Derivatives: A Kinetic, In Silico , and In Vitro Approach. ACS omega 8 (49) (2023)
Momin Khan, Hina Gohar, Aftab Alam, Abdul Wadood, Azam Shareef, Mahboob Ali, Asaad Khalid, Ashraf N Abdalla, Farhat Ullah
Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study. ACS omega 8 (5) (2023)
Mohammad Ibrahim, Hazrat Un Nabi, Niaz Muhammad, Muhammad Ikram, Momin Khan, Musadiq Ibrahim, Abdullah F AlAsmari, Metab Alharbi, Abdulrahman Alshammari
Synthesis, Antioxidant, Molecular Docking and DNA Interaction Studies of Metal-Based Imine Derivatives. Molecules (Basel, Switzerland) 28 (15) (2023)
Sajjad Ahmad, Momin Khan, Aftab Alam, Amar Ajmal, Abdul Wadood, Azim Khan, Abdullah F AlAsmari, Metab Alharbi, Abdulrahman Alshammari, Abdul Shakoor
Novel flurbiprofen clubbed oxadiazole derivatives as potential urease inhibitors and their molecular docking study. RSC advances 13 (37) (2023)
Momin Khan, Hina Gohar, Aftab Alam, Abdul Wadood, Azam Shareef, Mahboob Ali, Asaad Khalid, Ashraf N Abdalla, Farhat Ullah
Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study. ACS omega 8 (5) (2023)
Farida Begum, Muhammad Yousaf, Sajid Iqbal, Nazif Ullah, Anwar Hussain, Momin Khan, Asaad Khalid, Alanood S Algarni, Ashraf N Abdalla, Ajmal Khan, Muhammad Arif Lodhi, Ahmed Al Harrasi
Inhibition of Acetylcholinesterase with Novel 1, 3, 4, Oxadiazole Derivatives: A Kinetic, In Silico , and In Vitro Approach. ACS omega 8 (49) (2023)
Maryam Iqbal, Sulaiman Shams, Huma Rafiq, Momin Khan, Shahid Khan, Umer Sadique Khattak, Sahib Gul Afridi, Fehmida Bibi, Angham Abdulrhman Abdulkareem, Muhammad Imran Naseer
Combinatorial Therapeutic Potential of Stem Cells and Benzimidazol Derivatives for the Reduction of Liver Fibrosis. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Arif Ali, Muhammad Ishaq Ali Shah, Chaoping Fu, Zubair Hussain, Muhammad Nasimullah Qureshi, Saira Farman, Zahida Parveen, Amir Zada, Saira Nayab, Perveen Fazil, Muhammad Ateeq, Gauhar Rehman, Mohammad Naeem, Mohammad Ibrahim, Momin Khan, Waliullah Khan
Dihydropyrazole Derivatives Act as Potent α-Amylase Inhibitors and Free Radical Scavengers: Synthesis, Bioactivity Evaluation, Structure-Activity Relationship, ADMET, and Molecular Docking Studies. ACS omega 8 (23) (2023)
Sajjad Ahmad, Momin Khan, Muhammad Ishaq Ali Shah, Mahboob Ali, Aftab Alam, Muhammad Riaz, Khalid Mohammed Khand
Synthetic Transformation of 2-{2-Fluoro[1,1'-biphenyl]-4-yl} Propanoic Acid into Hydrazide-Hydrazone Derivatives: In Vitro Urease Inhibition and In Silico Study. ACS omega 7 (49) (2022)
Sajjad Ahmad, Momin Khan, Muhammad Ishaq Ali Shah, Mahboob Ali, Aftab Alam, Muhammad Riaz, Khalid Mohammed Khand
Synthetic Transformation of 2-{2-Fluoro[1,1'-biphenyl]-4-yl} Propanoic Acid into Hydrazide-Hydrazone Derivatives: In Vitro Urease Inhibition and In Silico Study. ACS omega 7 (49) (2022)